Taken together, our results support the hypothesis that FGFR2 crosstalk has a dual role in the endometrium, by regulating cell proliferation in normal endometrium, but acting as an oncogene in endometrial carcinoma (Figure 8). This evidence concerns the gene FGFR2 and endometrial carcinoma.